Inventor · disambiguated record
Rashida A. Karmali
Also filed as: KARMALI RASHIDA · KARMALI RASHIDA A
19 granted patents·3 pending applications·178 citations·filing 1999–2021
93Inventor score
Top patents by PatentIndex Score
22 records- 0186US7378054B2Specimen collecting, processing and analytical assemblySAVVIPHARM INC·Filed 2004·Granted May 27, 2008·65 cites·11 claims
- 0282US8034823B2Method of increasing drug oral bioavailability and compositions of less toxic orotate saltsSAVVIPHARM INC·Filed 2005·Granted Oct 11, 2011·6 cites·29 claims
- 0382US7470672B2Compositions and methods of reducing tissue levels of drugs when given as orotate derivativesSAVVIPHARM INC·Filed 2006·Granted Dec 30, 2008·1 cites·2 claims
- 0481US9089570B2Compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotateKARMALI RASHIDA A·Filed 2013·Granted Jul 28, 2015·2 cites·19 claims
- 0581US6239137B1Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activitySAVVIPHARM INC·Filed 1999·Granted May 29, 2001·47 cites·51 claims
- 0680US10378059B2Methods and molecular pharmacodynamic biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotateKARMALI RASHIDA A·Filed 2013·Granted Aug 13, 2019·2 cites·28 claims
- 0776US8912223B2Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulationsKARMALI RASHIDA A·Filed 2013·Granted Dec 16, 2014·1 cites·20 claims
- 0875US8148339B2Method of reducing cardiac levels of doxorubicin when given as orotate saltKARMALI RASHIDA A·Filed 2008·Granted Apr 3, 2012·0 cites·5 claims
- 0974US7750018B2Use of carboxiamidotriazole (CAI) orotate in macular degenerationTACTICAL THERAPEUTICS INC·Filed 2006·Granted Jul 6, 2010·2 cites·1 claims
- 1073US8420658B2Use of Carboxyamidotriazole (CAI) orotate in macular degenerationKARMALI RASHIDA A·Filed 2010·Granted Apr 16, 2013·2 cites·1 claims
- 1172US7601834B2Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivativesSAVVIPHARM INC·Filed 2007·Granted Oct 13, 2009·1 cites·2 claims
- 1271US8877785B2Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotateKARMALI RASHIDA A·Filed 2012·Granted Nov 4, 2014·1 cites·5 claims
- 1370US8377973B2Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulationsTACTICAL THERAPEUTICS INC·Filed 2010·Granted Feb 19, 2013·2 cites·12 claims
- 1468US6184227B1Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseasesSAVVIPHARM INC·Filed 1999·Granted Feb 6, 2001·25 cites·20 claims
- 1564US8802831B2Compositions and methods of improving the tolerability of daunorubicin when given as orotate saltKARMALI RASHIDA A·Filed 2012·Granted Aug 12, 2014·0 cites·2 claims
- 1655US11318118B1Methods and compositions for treating SARS-CoV-2 infection using carboxyamidotriazole orotateKARMALI RASHIDA A·Filed 2021·Granted May 3, 2022·0 cites·8 claims
- 1755US8415388B2Pharmaceutical compositions containing paclitaxel orotateKARMALI RASHIDA A·Filed 2011·Granted Apr 9, 2013·0 cites·2 claims
- 1853US2002147676A1Computerized evaluation of risk in financing tecnologiesFiled 2001·Application pending·0 cites
- 1952US2022168276A1Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole OrotateKARMALI RASHIDA A·Filed 2020·Application pending·0 cites
- 2048USD465641SCool capFiled 2000·Granted Nov 19, 2002·8 cites·1 claims
- 2143US6243876B1Kool capFiled 1999·Granted Jun 12, 2001·13 cites·1 claims
- 2240US2016367553A1Methods and Compositions for Treating Cancers having Acquired Resitance to prior Chemotherapeutic and Targeted Drugs Using Carboxyamidotriazole OrotateKARMALI RASHIDA A·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rashida A. Karmali files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →